This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
by Zacks Equity Research
McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
McKesson (MCK) Tops Q4 Earnings Estimates
by Zacks Equity Research
McKesson (MCK) delivered earnings and revenue surprises of 3.16% and 3.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for McKesson (MCK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
by Zacks Equity Research
McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
McKesson (MCK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for McKesson (MCK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Henry Schein (HSIC) Q1 Earnings Beat Estimates
by Zacks Equity Research
Henry Schein (HSIC) delivered earnings and revenue surprises of 3.60% and 1.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Laps the Stock Market: Here's Why
by Zacks Equity Research
McKesson (MCK) closed at $712.79 in the latest trading session, marking a +0.78% move from the prior day.
McKesson (MCK) Rises Higher Than Market: Key Facts
by Zacks Equity Research
McKesson (MCK) reachead $699.73 at the closing of the latest trading day, reflecting a +0.68% change compared to its last close.
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Merit Medical (MMSI) delivered earnings and revenue surprises of 14.67% and 0.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, McKesson (MCK) closed at $695.17, marking a +1.86% move from the previous day.
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, McKesson (MCK) closed at $694.70, indicating a +0.27% shift from the previous trading day.
Why the Market Dipped But McKesson (MCK) Gained Today
by Zacks Equity Research
McKesson (MCK) closed the most recent trading day at $679.33, moving +1.13% from the previous trading session.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Stock Moves -1.38%: What You Should Know
by Zacks Equity Research
McKesson (MCK) closed the most recent trading day at $652.83, moving -1.38% from the previous trading session.
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business
by Zacks Equity Research
McKesson acquires 80% ownership in PRISM Vision Holdings, diversifying its business into the high-growth area of ophthalmology. The deal is to be accretive this year.
McKesson (MCK) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the most recent trading session, McKesson (MCK) closed at $672.99, indicating a +0.74% shift from the previous trading day.
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), McKesson (MCK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
McKesson (MCK) closed at $660.86 in the latest trading session, marking a -0.05% move from the prior day.
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, McKesson (MCK) closed at $663.79, marking a +0.33% move from the previous day.